EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 54 / No 2 (June 2022) J Extra Corpor Technol, 54 2 (2022) 153-160 References
Free Access
Review
Issue
J Extra Corpor Technol
Volume 54, Number 2, June 2022
Page(s) 153 - 160
DOI https://doi.org/10.1051/ject/202254153
Published online 15 June 2022
  1. Davidson SJ, Tillyer ML, Keogh J, et al. Heparin concentrations in neonates during cardiopulmonary bypass. J Thromb Haemost. 2012;10:730–2. [CrossRef] [Google Scholar]
  2. Codispoti M, Ludlam CA, Simpson D, et al. Individualized heparin and protamine management in infants and children undergoing cardiac operations. Ann Thorac Surg. 2001;71:922–7. [CrossRef] [Google Scholar]
  3. Guzzetta NA, Bajaj T, Fazlollah T, et al. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Anesth Analg. 2008;106:419–25. [CrossRef] [PubMed] [Google Scholar]
  4. Despotis GJ, Joist JH, Hogue CW, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation: A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995:46–52. [Google Scholar]
  5. Guzzetta NA, Miller BE, Todd K, et al. An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates. Anesth Analg. 2005;100:1276–82. [CrossRef] [PubMed] [Google Scholar]
  6. Gravlee GP, Davis RF, Hammon JW, et al. Cardiopulmonary bypass and mechanical support: Principles and practice. Philadelphia. Wolters Kluwer. 2016;430:475. [Google Scholar]
  7. Manlhiot C, Gruenwald CE, Holtby HM, et al. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity. J Thorac Cardiovasc Surg. 2016;151:446–7. [Google Scholar]
  8. Dietrich W, Braun S, Spannagl M, et al. Low preoperative antithrombin activity causes reduced response to heparin in adult but not in infant cardiac-surgical patients. Anesth Analg. 2001;92:67–8. [Google Scholar]
  9. Jooste EH, Scholl R, Wu Y-H, et al. Double-blind, randomized, placebo-controlled trial comparing the effects of antithrombin versus placebo on the coagulation system in infants with low antithrombin undergoing congenital cardiac surgery. J Cardiothorac Vasc Anesth. 2018;33:369–401. [Google Scholar]
  10. Hashimoto K, Yamagishi M, Sasaki T, et al. Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg. 1994;58:800–3. [Google Scholar]
  11. D’Errico C, Shayevitz JR, Martindale SJ. Age-related differences in heparin sensitivity and heparin-protamine interactions in cardiac surgery patients. J Cardiothorac Vasc Anesth. 1996;10:451–7. [CrossRef] [Google Scholar]
  12. Hikino K, Koido M, Ide K, et al. Individual variation in unfractionated heparin dosing after pediatric cardiac surgery. Natnews. 2020;10:1–4. [Google Scholar]
  13. Gruenwald CE, Manlhiot C, Crawford-Lean L, et al. Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. J Extra Corpor Technol. 2010;42:9–19. [Google Scholar]
  14. Gruenwald C, De Souza V, Chan AK, et al. Whole blood heparin concentrations do not correlate with plasma antifactor XA heparin concentrations in pediatric patients UNDERGOING cardiopulmonary bypass. Perfusion. 2000;15:203–9. [CrossRef] [PubMed] [Google Scholar]
  15. Kern FH, Morana NJ, Sears JJ, et al. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg. 1992;92:542–5. [Google Scholar]
  16. Fesseau R, Alacoque X, Hascoet S, et al. ACT variation after a weight-based heparin bolus before CPB is not predictable in infant. Arch Cardiovasc Dis. 2014;107:495. [CrossRef] [Google Scholar]
  17. Gruenwald CE, Manlhiot C, Chan AK, et al. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass. J Am Coll Cardiol. 2010;56:1794–802. [CrossRef] [Google Scholar]
  18. Davidson SJ, Tillyer ML, Keogh J, et al. Heparin concentrations in neonates during cardiopulmonary bypass. J Thromb Haemost. 2012;10:730–2. [CrossRef] [Google Scholar]
  19. Chen K, Tanzola R, Quest G, et al. Correlation between activated clotting time and anti-xa activity in patients undergoing cardiac surgery requiring cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2020;34: S21–2. [Google Scholar]
  20. Shirota K, Watanabe T, Takagi Y, et al. Maintenance of Blood Heparin Concentration Rather Than Activated Clotting Time Better Preserves the Coagulation System in Hypothermic Cardiopulmonary Bypass. Nagoya, Japan: Wiley Online Library; 2001. [Google Scholar]
  21. Guzzetta NA, Miller BE, Knezevic A, et al. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass. Surv Anesthesiol. 2011;55:61–2. [CrossRef] [Google Scholar]
  22. Slight RD, Buell R, Nzewi OC, et al. A comparison of activated coagulation time–based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2007;2:47–52. [Google Scholar]
  23. Owings JT, Pollock ME, Gosselin RC, et al. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques. Arch Surg. 2000;135:1042–7. [CrossRef] [Google Scholar]
  24. Nybo M, Madsen JS. Serious Anaphylactic Reactions due to Protamine Sulfate: A Systematic Literature Review. Odense, Denmark: Wiley Online Library; 2008. [Google Scholar]
  25. Seifert HA, Jobes DR, Ten Have T, et al. Adverse events after protamine administration following cardiopulmonary bypass in infants and children. Anesth Analg. 2003;97:383–9. [CrossRef] [PubMed] [Google Scholar]
  26. Caneo LF, Matte G, Frey T. Minimizing the need for transfusion in pediatric congenital heart surgery. International Journal of Clinical Transfusion Medicine. 2019;7:1–9. [CrossRef] [Google Scholar]
  27. Meesters MI, Veerhoek D, Lange F, et al. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Thromb Haemost. 2016;116:251–61. [Google Scholar]
  28. DeLaria GA, Tyner JJ, Hayes CL, et al. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery. Arch Surg. 1994;129:945. [CrossRef] [Google Scholar]
  29. Williams GD, Bratton SL, Riley EC, et al. Association between age and blood loss in children undergoing open heart operations. Ann Thorac Surg. 1998;66:870–5. [CrossRef] [Google Scholar]
  30. Manno C, Hedberg K, Kim H, et al. Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood. 1991;77:930–6. [CrossRef] [PubMed] [Google Scholar]
  31. Cholette JM, Pietropaoli AP, Henrichs KF, et al. Longer RBC storage duration is associated with increased postoperative infections in pediatric cardiac surgery. Pediatr Crit Care Med. 2015;16:227–35. [CrossRef] [PubMed] [Google Scholar]
  32. Nakamura S, Honjo O, Crawford-Lean L, et al. Predicting heparin responsiveness in children before cardiopulmonary bypass: A retrospective cohort study. Anesth Analg. 2018;126:1617–23. [CrossRef] [PubMed] [Google Scholar]
  33. Riley W, Lee MH. Factors associated with errors in the heparin dose response test: Recommendations to improve individualized heparin management in cardiopulmonary bypass. Perfusion. 2020;36:513–23. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.